Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer

Fig. 7

Analysis CA19-9 levels present in whole blood from PC patients. a ELISA CA19-9 results indicating the overexpression of the proteins in the exosomes isolated from PC patients compared with healthy donors. b Serum CA19-9 levels and exosomal CA19-9 levels in PC patients. The PC patient II represents the false negative case, whose free serum CA19-9 levels were in the normal range whereas the exosomal CA19-9 levels were significantly increased

Back to article page